Pharmacokinetics and Bioavailability of Captopril in Healthy Volunteers
Yang Wanxin
Abstract
Yang Wanxin
Abstract
OBJECTIVES:To compare the bioavailability and pharmacokinetics of captopril between products of two factories.METHODS:An open randomized crossover study was carried out in 9 healthy volunteers who received a single oral dose of 30mg captopril,taking β bromophenacyl bromide as ramification.Drug concentrations in plasma were assayed by HPLC method.RESULTS:The concentration time course after medication conformed to a 2 compartment open model with a first order absorption.The pharmacokinetic parameters of Captopril of A and B medicine factories were:Tmax(0.94±0.13)h,(1.00±0.15)h,Cmax(92.03±27.36)ng/ml,(74.67±19.29)ng/ml,AUC(252.78±68.14)ng/(h·L),(251.19±50.13)ng/(h·L)respectively.CONCLUSIONS:The results showed that the bioavailability for the testing tablet was 99.37%,the two formulations were bioequivalent.
A significance statement is not available in the OpenAlex record.
A contribution statement is not available in the OpenAlex record.
Method details are not available in the OpenAlex metadata.
Findings are not separately available in the OpenAlex metadata.
Limitations are not available in the OpenAlex metadata.
Application details are not available in the OpenAlex metadata.
OBJECTIVES:To compare the bioavailability and pharmacokinetics of captopril between products of two factories.METHODS:An open randomized crossover study was carried out in 9 healthy volunteers who received a single oral dose of 30mg captopril,taking β bromophenacyl bromide as ramification.Drug concentrations in plasma were assayed by HPLC method.RESULTS:The concentration time course after medication conformed to a 2 compartment open model with a first order absorption.The pharmacokinetic parameters of Captopril of A and B medicine factories were:Tmax(0.94±0.13)h,(1.00±0.15)h,Cmax(92.03±27.36)ng/ml,(74.67±19.29)ng/ml,AUC(252.78±68.14)ng/(h·L),(251.19±50.13)ng/(h·L)respectively.CONCLUSIONS:The results showed that the bioavailability for the testing tablet was 99.37%,the two formulations were bioequivalent.
Key concepts: Bioavailability, Pharmacokinetics, Bioequivalence, Captopril, Cmax, Pharmacology, Crossover study, Chemistry